Add BrightSurf on Google Email

Study highlights from November issue of GIE: Gastrointestinal Endoscopy

A recent study published in the November issue of Gastrointestinal Endoscopy found that six percent of asymptomatic women underwent endoscopic screening and were diagnosed with Barrett's esophagus. Additionally, researchers demonstrated the accuracy of EUS-FNA in diagnosing pancreatic endocrine tumors, predicting five-year survival rat...

SourceAmerican Society for Gastrointestinal Endoscopy·JournalGastrointestinal Endoscopy·DateNov 23, 2009

What is the etiology of cardiac syndrome X?

A study published in the World Journal of Gastroenterology found that almost 30% of patients with CSX no longer exhibited typical chest pain after gastroenterological workup. Treatment with proton pump inhibitors significantly improved symptoms, suggesting a strong link between acid-related disorders and CSX.

SourceWorld Journal of Gastroenterology·JournalWorld Journal of Gastroenterology·DateNov 27, 2008

Enzyme inhibitor may provide strategy to treat some GI disorders, Jefferson researchers find

Researchers at Thomas Jefferson University found that blocking Rho kinase activity could be a viable treatment for gastrointestinal disorders such as constipation, anal fissures, and hemorrhoids. The study showed that Rho kinase inhibitors can cause direct smooth muscle relaxation and may provide a new strategy to treat these conditions.

SourceThomas Jefferson University·JournalGASTROENTEROLOGY·DateJul 18, 2006

Health in a 24-hour society

A review article in The Lancet highlights the negative effects of shift work on health and productivity. Desynchronisation of circadian rhythms can lead to poor sleep, gastrointestinal disorders, and cardiovascular disease, emphasizing the need for employers to create effective working environments.

SourceThe Lancet_DELETED·JournalThe Lancet·DateSep 20, 2001

Team identifies first drug therapy for rare, precancerous stomach illness

Researchers at Vanderbilt University Medical Center have identified a new drug therapy that appears to be effective in reversing symptoms of Ménétrier's disease, a rare and premalignant stomach disorder. The treatment, which blocks activation of the EGF receptor, showed promising results in a patient with severe vomiting and protein loss.

SourceVanderbilt University Medical Center·JournalNew England Journal of Medicine·DateDec 6, 2000

Free radicals in alcoholic liver disease

A new study reveals that free radicals, generated by the macrophage enzyme NADPH oxidase, are essential for the development of alcoholic liver disease. The researchers found that mice lacking this enzyme were resistant to liver injury and had lower levels of covalent adducts in their bile.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateSep 30, 2000